Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.

Advances in experimental medicine and biology - 1 Jan 2016

Terry Mary Beth, McDonald Jasmine A, Wu Hui Chen, Eng Sybil, Santella Regina M

Abstract excerpt

Epigenetic biomarkers, such as DNA methylation, can increase cancer risk through altering gene expression. The Cancer Genome Atlas (TCGA) Network has demonstrated breast cancer-specific DNA methylation signatures. DNA methylation signatures measured at the time of diagnosis may prove important for treatment options and in predicting disease-free and overall survival (tertiary prevention). DNA methylation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Early Detection of Cancer

Share to Epigenesis, Genetic

Share to Neoplasm Recurrence, Local

Share to Predictive Value of Tests

Share to Primary Prevention

Share to Secondary Prevention

Source

Open in PubMed Open full text

Identifiers

PMID: 26987530
DOI: 10.1007/978-3-319-22909-6_2
PMCID: PMC5305320

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.PMID 26987530Read ↗

DNA methylation biomarkers for the diagnosis and treatment management of breast cancer: where are we now?Semantic proximity Read ↗

Blood DNA methylation biomarkers for breast cancer riskSemantic proximity Read ↗

Epigenetic Biomarkers for Environmental Exposures and Personalized Breast Cancer PreventionSemantic proximity Read ↗

The Role of Methylation in Breast Cancer Susceptibility and Treatment.Semantic proximity Read ↗

Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencingSemantic proximity Read ↗

Molecular screening for breast cancer prevention, early detection, and treatment planning: combining biomarkers from DNA, RNA, and protein.Semantic proximity Read ↗

Blood DNA methylation and breast cancer risk: a prospective nested case-control study.Semantic proximity Read ↗

Breast cancer biomarkers and molecular medicine.Semantic proximity Read ↗

Genetic and epigenetic biomarkers in cancer : improving diagnosis, risk assessment, and disease stratification.Semantic proximity Read ↗

Integrating DNA methylation measures to improve clinical risk assessment: are we there yet? The case of BRCA1 methylation marks to improve clinical risk assessment of breast cancer.Semantic proximity Read ↗

Host Factors and Risk of Breast Cancer Recurrence: Genetic, Epigenetic and Biologic Factors and Breast Cancer Outcomes.Semantic proximity Read ↗

Circulating cell-free DNA-based epigenetic assay can detect early breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.